Proud mentor alert: Etienne Leveille gave a spectacular overview of our work at the first international meeting on 'Oncogene hyperactivation' as a new paradigm to treat cancer. Harnessing oncogene hyperactivation to induce negative selection in B-cell malignancies.

Dr. David Braun and Dr. Patrick Kenney discuss unmet needs in kidney cancer. Yale Urology David Braun Patrick Kenney #urology #kcsm
urologytimes.com/view/dr-braun-…

Very proud of Lena presenting her work at AAI - outstanding job!!
Yale Cancer Center Yale Department of Immunobiology

.David Braun, of Yale Cancer Center, highlights recent data focused on nivolumab plus cabozantinib in patients with non–clear cell renal cell carcinoma. #KidneyCancer #kcsm onclive.com/view/nivolumab…

⏰Don't miss the #KCRS24 abstract submission deadline, folks!
Excellent opportunity to learn latest advancements in #KidneyCancer research, meet the #GUOnc community and build new collaborations.
📅 Mon 5/6
Link 👉tinyurl.com/3xthrwk4
Hope to see you all in Boston!…

Thank you Neeraj Agarwal, MD, FASCO and Chadi Hage Chehade for this excellent commentary discussing our work in Cancer Cell!
Yale Cancer Center Yale Pathology Yale Urology Yale School of Medicine

Just in Cancer Cell 👉Validation of the molecular clusters of the IMmotion151 trial in the JAVELIN Renal 101 dataset #kidneycancer : Excellent commentary highlighting these biomarkers by our fellow Chadi Hage Chehade 👇tinyurl.com/48px5rw8 GU Cancer Research Program @HuntsmanCancer OncoAlert UroToday.com KidneyCAN

Even more enthusiastic about joining Yale Internal Medicine Yale Traditional Medicine Residency Program after listening to the 'State of the Cancer Center' by Eric Winer, MD

So many giants to learn from with a a wonderful culture and vision! David Braun

Phenomenal 'debate' session highlighting the challenges in IMDC favorable risk, and strategies for choosing a comparator arm for future trials. Tremendously thoughtful discussions from Cris Ignacio Duran Martin Voss and Dr. Bernard Escudier #IKCSEU24 Kidney Cancer

Phenomenal to see all of the patient-centered programs for patients with RCC at Kidney Cancer , presented by Salvatore La Rosa #IKCSEU24

A mother fighting to stay alive for her young children. A young woman sharing her experience with debilitating side effects. Real stories of people living with #kidneycancer . Thank you Kidney Cancer for hosting this panel at #IKCSEU24 . Thank you to these brave pts for sharing.

Dr. David Cell Northwestern Feinberg School of Medicine discussing a latent class analysis to identify groups of patients with similar symptoms reported by FKSI19 #IKCSEU24 Kidney Cancer

An outstanding and comprehensive overview of chromophobe RCC biology by Martin Voss #IKCSEU24 . Please see the recent review for more discussion on the biology of this tumor type in Cancer Cell cell.com/cancer-cell/ab…
Kidney Cancer

Congratulations to Manuela Schmidinger on the extremely well deserved award! #IKCSEU24 KidneyCancers.org

Dr. Ferran Algaba Arrea providing an excellent overview of the increasingly complex classification, including correlations between morphological features and molecular alterations #IKCSEU24 Kidney Cancer

Really important talk from Turajlic Lab @ The Crick about genomic -> transcriptomic -> proteomic tools for classifications, including challenges and strategies for effective molecular classification and biomarker development #IKCSEU24 Kidney Cancer

An excellent, balanced discussion of adjuvant therapy in RCC from Brian Rini, MD Tom Powles Uromigos . An area of consensus - we need better ways to risk stratification risk of recurrence, including biomarkers #IKCSEU24 Kidney Cancer

Dr. Axel Bex and Arnaud Méjean, MD, PhD with a friendly debate on management of positive surgical margins after partial nephrectomy #IKCSEU24 Kidney Cancer

Excited to start #IKCSEU24 . First with a bit of history of this beautiful city Sitges Kidney Cancer

Excited to share our work The Oncologist co-led by Georges Gebrael and mentored by Toni Choueiri, MD Daniel Heng

While smoking cessation is crucial 🚭, smoking status does not independently affect outcomes in pts w/ #mRCC treated w/ 1L ICI

OncoAlert UroToday.com
tinyurl.com/mv44nycci